Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of DNAJC10 mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of DNAJC10 protein | affects expression | 20106945
|
D001205 |
Ascorbic Acid |
Ascorbic Acid inhibits the reaction [Fenretinide results in increased expression of DNAJC10 mRNA] | decreases reaction|increases expression | 17353921
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DNAJC10 mRNA | decreases expression | 20018196
|
D003010 |
Clorgyline |
Clorgyline results in increased expression of DNAJC10 mRNA | increases expression | 19691856
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of DNAJC10 mRNA | increases expression | 20106945
|
D017313 |
Fenretinide |
Ascorbic Acid inhibits the reaction [Fenretinide results in increased expression of DNAJC10 mRNA] | decreases reaction|increases expression | 17353921
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of DNAJC10 mRNA | increases expression | 17353921
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DNAJC10 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of DNAJC10 mRNA | decreases expression | 17426115
|
C031280 |
pyrazole |
pyrazole results in increased expression of DNAJC10 mRNA | increases expression | 17945193
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DNAJC10 mRNA | decreases expression | 17101203
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of DNAJC10 mRNA | increases expression | 17353921
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.27 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
3.14 | 10697514 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.56 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.56 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.24 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.24 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.48 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
2.07 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
2.07 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.83 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.83 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
4.83 | 17159502 16270382 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
3.21 | 16274795 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.69 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.69 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.69 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.67 | 16154183 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.10 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.10 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 15340226 16354765 12621046 8697196 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.68 | 17273769 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.69 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.19 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
4.65 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.65 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.53 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
6.53 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.53 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.69 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.00 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.00 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 15322242 16714409 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.10 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.03 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.03 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.07 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.07 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
3.98 | 16187019 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
7.08 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
7.08 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.62 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.85 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.85 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.51 | 16490937 16863852 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 15340226 8697196 16354765 16959395 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.10 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.10 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.92 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.41 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.67 | 12371664 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
6.26 | 16707609 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.17 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.17 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.07 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
11.07 | 9163691 18177683 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.07 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.07 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.86 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.86 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
14.86 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.86 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
4.04 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.59 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
3.59 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.59 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
3.65 | 10697514 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
2.84 | 16270382 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
4.42 | 16274795 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.19 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.05 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
therapeutic |
|
| 17353921 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
5.45 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.45 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.41 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.87 | 16303764 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
4.85 | 17217161 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.85 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.56 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
3.27 | 16133793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
3.39 | 15580305 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.35 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11896295 11222880 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
Clorgyline |
3.93 | 19691856 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
3.93 | 17024972 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
5.55 | 14606601 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.50 | 16303925 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.34 | 16849425 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.62 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.24 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
6.09 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.09 | 16192470 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
4.03 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
4.40 | 16517955 16403987 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
5.01 | 6499806 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.55 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
5.55 | 16720286 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.51 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
4.69 | 16154183 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |